Quality Decision Making in Health Technology Assessment: Issues Facing Companies and Agencies
View/ Open
Author
Bujar, M
McAuslane, N
Stuart, Walker
Salek, Sam
Attention
2299/24495
Abstract
Background:To evaluate the quality of the decision-making processes of pharmaceutical companies during medicines development for evidence generation to support reimbursement of new medicines and the appraisal recommendation decision-making process by health technology assessment (HTA) agencies.Methods:Two questionnaires were developed and subsequently piloted for the purpose of content validation. These were sent to 24 pharmaceutical companies and 16 HTA agencies.Results:Responses were obtained from 11 companies and 11 HTA agencies. Some similarities were identified between the decision-making processes of companies and agencies, such as the use of committees, having a primarily mixed (qualitative/quantitative) internal decisionmaking system, as well as the lack of systematic assessments of quality decision making and the relatively infrequent use of formal decision-making frameworks. Nevertheless, the results indicate differences as companies and agencies use diverse processes to arrive at the final decision either through consensus, majority vote, or an individual making the decision. The majority of companies and agencies believe that the quality of decision making can and should be measured. Moreover, organizations considered the occurrence of biases within their organization as pertinent. Finally, almost all the participants felt that there was room for improvement for their organization’s quality of decision making.Conclusion:These findings are consistent with a published study on regulatory processes and support the need for more consistent and predictable decision-making processes during the life cycle of medicines. This could be achieved through capacity building, systematically evaluating the quality of decision making, and encouraging utilization of formal decision-making frameworks within companies and agencies.
Publication date
2020-03-01Published in
Therapeutic Innovation & Regulatory SciencePublished version
https://doi.org/10.1007/s43441-019-00054-wOther links
http://hdl.handle.net/2299/24495Metadata
Show full item recordRelated items
Showing items related by title, author, creator and subject.
-
Assessing the quality of decision support technologies using the International Patient Decision Aid Standards instrument (IPDASi)
Elwyn, Glyn; O'Connor, Annette M; Bennett, Carol; Newcombe, Robert G; Politi, Mary; Durand, Marie-Anne; Drake, Elizabeth; Joseph-Williams, Natalie; Khangura, Sara; Saarimaki, Anton; Sivell, Stephanie; Stiel, Mareike; Bernstein, Steven J; Col, Nananda; Coulter, Angela; Eden, Karen; Härter, Martin; Rovner, Margaret Holmes; Moumjid, Nora; Stacey, Dawn; Thomson, Richard; Whelan, Tim; van der Weijden, Trudy; Edwards, Adrian (2009)To describe the development, validation and inter-rater reliability of an instrument to measure the quality of patient decision support technologies (decision aids). -
A Hybrid Hierarchical Decision Support System for Cardiac Surgical Intensive Care Patients. Part I : Physiological Modeling and Decision Support Design
Denai, Mouloud; Mahfouf, M.; Ross, J.J. (2009-01)To develop a clinical decision support system (CDSS) that models the different levels of the clinician's decision-making strategies when controlling post cardiac surgery patients weaned from cardio pulmonary bypass -
The Integration of Personal and Professional Ethical Decision Making Constructs in Trainee Clinical Psychologists
Jenkin, Angela (2018-09-26)Ethical decision-making is an important but challenging aspect of the role of a clinical psychologist. Little research has been conducted concerning how clinical psychologists make ethical decisions, with even less known ...